RO-5006036(939375-07-2)
- Name: RO-5006036
- Synonyms:DGAT1-IN-3;RO-5006036;4-Oxazolecarboxamide, N-[6-[(2-methoxyethyl)methylamino]-3-pyridinyl]-2-phenyl-5-(trifluoromethyl)-;N-[6-[2-methoxyethyl(methyl)amino]pyridin-3-yl]-2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxamide
- Molecular Formula:C20H19F3N4O3
- Molecular Weight:420.391
- CAS Registry Number:939375-07-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.939375-07-2 RO-5006036
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:RO-5006036
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.939375-07-2 Dgat1-IN-3;939375-07-2
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 1228690-36-5/AM095
- 243982-58-3/PDHK inhibitor
- 1072906-04-7/Ethanamine, 2-(5-bromo-2-nitrophenoxy)-N,N-dimethyl-
- 1065559-56-9/SMND-309
- 1188910-76-0/CEP-32496 (free base)
- 529488-28-6/Genz644282
- 331244-89-4/BAM7
- 1065473-66-6/2-Buten-1-one, 1-[(2S)-2-[[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-1-pyrrolidinyl]-4-(dimethylamino)-, (2E)-
- 1218778-77-8/LDE-225 Diphosphate
- 1197406-41-9/1,3,5-Triazine-2,4-diamine, N2-(2,3-dihydro-1H-inden-2-yl)-6-(1-piperazinyl)-N4-4-pyridinyl-
- 956906-93-7/PF 04217903 mesylate
- 1197341-62-0/1,3,5-Triazine-2,4-diamine, N2-(2,3-dihydro-1H-inden-2-yl)-6-(1-piperazinyl)-N4-4-pyridinyl-, (Hydrochloride) (1:1)
- 153653-31-7/Dofequidar (S)-isomer
- 959986-66-4/4-iodo-1-Methyl-1H-pyrazole-5-carbaldehyde
- 153653-33-9/Dofequidar (R)-isomer
- 1190378-57-4/N-[3-[[5-Cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide
- 939375-07-2/RO-5006036
- 1220171-17-4/CCR1 antagonist 5
- 104846-63-1/tert-butyl((E)-3-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexyloxy)diMethylsilane
- 1184940-47-3/(alphaR)-3,5-Difluoro-alpha-hydroxybenzeneacetic acid 2-(2-ethyl-4-hydroxy-3-methylbenzoyl)hydrazide
- 761436-81-1/ALK inhibitor 1
- 895158-95-9/SC 144
- 865479-71-6/5-R-Rivaroxaban
- 620616-08-2/Benzeneethanol, β-aMino-3-chloro-, hydrochloride (1:1), (βS)-
- 554435-83-5/Exjade Fe3+ chelate
- 159878-04-3/[3S-(3S,4aS,8aS,2’R,3’R)]-2-[3’-N-CBz-amino-2’-hydroxy-4’-(phenyl)thio]butyldecahydroisoquinoline-3-N-t-butylcarboxamide
- 220662-95-3/RJR-2403 (oxalate)
- 864668-87-1/ENMD-119
- 1011557-82-6/Tenovin-6
- 557766-14-0/Benzo[3,4]-18-norandrosta-3,5-diene-3(2'H)-carboxylic acid, 3',4',5',6'-tetrahydro-17-(hydroxyimino)-4',4',9,14-tetramethyl-, methyl ester, (3β,4β,8α,9β,10α,13α,14β)- (9CI)